Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
SmartMedia Technologies is the Enterprise SaaS Web3 platform the future is being built on.
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Developing the next-generation, AI-enabled commercial space station
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Calyxo is a medical device company that improves kidney stone treatment through specialized urology technologies.
Forte Biosciences is a biotechnology company that focuses on dermatology.
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.
Ovid Therapeutic's purpose is to solve intractable medical problems.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Janus Henderson Investors has invested in 229 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Biopharma, Life Science, Therapeutics. The firm invests across 21 different industry categories.
Among tracked funding rounds, Tango Therapeutics received $600.0M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $34.7B.
Janus Henderson Investors's average investment size is $151.4M across its portfolio of 229 companies.
Recent Janus Henderson Investors portfolio additions include Shattuck Labs, Tango Therapeutics, Element Biosciences, Entact Bio, Jade Biosciences. These companies were founded in 2020 or later.